ARTICLE | Company News
MacroGenics, Institute for Systems Biology, Rockefeller University deal
October 1, 2001 7:00 AM UTC
MacroGenics and the institute will identify cancer antigens, adjuvants and certain inflammatory disease targets using proteomics and genomics technologies. MacroGenics will develop monoclonal antibodi...